PATRYS Ltd (AU:PAB) — Market Cap & Net Worth
Market Cap & Net Worth: PATRYS Ltd (PAB)
PATRYS Ltd (AU:PAB) has a market capitalization of $7.96 Million (AU$11.24 Million) as of September 24, 2026. Listed on the AU stock exchange, this Australia-based company holds position #27708 globally and #1369 in its home market, demonstrating a -2.94% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying PATRYS Ltd's stock price AU$0.03 by its total outstanding shares 340728636 (340.73 Million). Also see PATRYS Ltd asset portfolio for a full breakdown of the balance sheet.
PATRYS Ltd Market Cap History: 2015 to 2026
PATRYS Ltd's market capitalization history from 2015 to 2026. Data shows growth from $1.83 Million to $7.96 Million (13.09% CAGR). Also see PATRYS Ltd operating cash flow efficiency for how efficiently the company converts equity into cash flow.
PATRYS Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how PATRYS Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check PAB share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
8.15x
PATRYS Ltd's market cap is 8.15 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.37 Million | $274.97K | -$1.08 Million | 5.00x | N/A |
| 2017 | $5.30 Million | $53.26K | -$1.06 Million | 99.58x | N/A |
| 2018 | $6.44 Million | $520.52K | -$2.50 Million | 12.37x | N/A |
| 2019 | $4.77 Million | $844.37K | -$411.33K | 5.65x | N/A |
| 2020 | $5.76 Million | $27.50K | -$2.75 Million | 209.53x | N/A |
| 2021 | $8.92 Million | $27.50K | -$4.06 Million | 324.37x | N/A |
| 2022 | $6.51 Million | $27.50K | -$6.78 Million | 236.70x | N/A |
| 2023 | $1.93 Million | $2.85 Million | -$7.06 Million | 0.68x | N/A |
| 2024 | $964.35K | $1.39 Million | -$3.54 Million | 0.69x | N/A |
| 2025 | $6.75 Million | $828.54K | -$3.01 Million | 8.15x | N/A |
Competitor Companies of PAB by Market Capitalization
Companies near PATRYS Ltd in the global market cap rankings as of September 24, 2026. Review PAB goodwill-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to PATRYS Ltd by market ranking:
- ECP Emerging Growth Ltd (AU:ECP): Ranked #27699 globally with a market cap of $7.99 Million USD ( AU$11.29 Million AUD).
- Epsilon Healthcare Ltd (AU:EPN): Ranked #27700 globally with a market cap of $7.98 Million USD ( AU$11.28 Million AUD).
- Telecom Plus PLC (LSE:TEP): Ranked #27709 globally with a market cap of $7.96 Million USD ( GBX65.39 Billion GBX).
- Rochester Resources Ltd (V:RCT): Ranked #27710 globally with a market cap of $7.95 Million USD ( CA$10.99 Million CAD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #27699 | ECP Emerging Growth Ltd | AU:ECP | $7.99 Million | AU$0.61 |
| #27700 | Epsilon Healthcare Ltd | AU:EPN | $7.98 Million | AU$0.03 |
| #27709 | Telecom Plus PLC | LSE:TEP | $7.96 Million | GBX819.00 |
| #27710 | Rochester Resources Ltd | V:RCT | $7.95 Million | CA$0.23 |
PATRYS Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, PATRYS Ltd's market cap moved from $1.83 Million to $ 7.96 Million, with a yearly change of 13.09%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$7.96 Million | +17.86% |
| 2025 | AU$6.75 Million | +600.00% |
| 2024 | AU$964.35K | -50.00% |
| 2023 | AU$1.93 Million | -70.37% |
| 2022 | AU$6.51 Million | -27.03% |
| 2021 | AU$8.92 Million | +54.81% |
| 2020 | AU$5.76 Million | +20.71% |
| 2019 | AU$4.77 Million | -25.84% |
| 2018 | AU$6.44 Million | +21.36% |
| 2017 | AU$5.30 Million | +285.96% |
| 2016 | AU$1.37 Million | -25.00% |
| 2015 | AU$1.83 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 23rd, 2026 the market cap of PATRYS Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $7.96 Million USD |
| MoneyControl | $7.96 Million USD |
| MarketWatch | $7.96 Million USD |
| marketcap.company | $7.96 Million USD |
| Reuters | $7.96 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About PATRYS Ltd
Patrys Limited, together with its subsidiaries, develops antibody technologies for the treatment of cancer and NETosis-driven inflammatory diseases. It develops PAT-DX1, a small antibody fragment derived from a humanized version of the binding domain from the original mouse deoxymab antibody 3E10; and PAT-DX3 for treating primary and secondary brain cancers, and metastases that are associated wit… Read more